Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Breast Cancer
Interventions
DRUG

OnLife®

"It is administered for the duration of PACLITAXEL chemotherapy with the first administration performed 5 days before the first PACLITAXEL administration. The OnLife supplement will be continued for another 4 weeks after the last PACLITAXEL administration.~One tablet in the morning and one in the evening daily"

OTHER

Placebo

"It is administered for the duration of PACLITAXEL chemotherapy with the first administration performed 5 days before the first PACLITAXEL administration. Placebo will be continued for another 4 weeks after the last PACLITAXEL administration.~One tablet in the morning and one in the evening daily"

Trial Locations (1)

21000

RECRUITING

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER